Sanofi to expand animal health business in India
PARIS (Reuters) - Sanofi (SASY.PA) said its Merial unit signed an agreement to buy the animal health business of drugmaker Dosch Pharmaceuticals to boost its presence in the growing Indian market.
The deal is expected to be finalised in the first half of 2013, Sanofi said on Thursday. Financial details were not disclosed.
Dosch's animal health business sells more than 86 products destined for livestock and pets, including medicines and feed supplements.
"The acquisition of Dosch's animal health division will be a significant milestone for Merial and give us a strategic platform for our development in the Indian market," Merial Chief Executive Jose Barella said in a statement.
Animal health is one of the businesses Sanofi is focusing on to drive growth after the loss of its top-selling drugs to generic rivals.
The animal health market in India was valued at more than 350 million euros in 2012 and is experiencing annual double-digit percentage growth, according to Sanofi data.
India is home to the world's largest herd of cattle and buffalo, second-largest herd of sheep and goats, and has the world's fifth-largest poultry population.
The country is also the world's largest milk producer.
Shares in Sanofi, which have risen around 26 percent since the start of 2012, were trading 0.5 percent higher at 71.51 euros at 1149 GMT, slightly outperforming the CAC 40 index, up 0.1 percent.
(Reporting by Elena Berton; Editing by Christian Plumb and James Regan)
- Tweet this
- Share this
- Digg this
DAVOS, Switzerland - Central banks have done their best to rescue the world economy by printing money and politicians must now act fast to enact structural reforms and pro-investment policies to boost growth, central bankers said on Saturday.
Trending On Reuters
India's largest carmaker Maruti Suzuki India Ltd posted a smaller-than-expected rise in profit for the third quarter, hit by one-off items including a jump in advertising costs, a higher tax rate and lower income from investments. Full Article | Full coverage